992
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Intra-cheek immunization as a novel vaccination route for therapeutic vaccines of head and neck squamous cell carcinomas using plasmo virus-like particles

, , , , , , , , , , , , & show all
Article: e1164363 | Received 30 Nov 2015, Accepted 07 Mar 2016, Published online: 06 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Jin Qiu, Shiwen Peng, Andrew Yang, Ying Ma, Liping Han, Max A. Cheng, Emily Farmer, Chien-Fu Hung & T.-C. Wu. (2018) Intramuscular vaccination targeting mucosal tumor draining lymph node enhances integrins-mediated CD8+ T cell infiltration to control mucosal tumor growth. OncoImmunology 7:8.
Read now

Articles from other publishers (8)

Sho Kawaguchi, Kenta Kawahara, Yukio Fujiwara, Koji Ohnishi, Cheng Pan, Hiromu Yano, Akiyuki Hirosue, Masashi Nagata, Masatoshi Hirayama, Junki Sakata, Hikaru Nakashima, Hidetaka Arita, Keisuke Yamana, Shunsuke Gohara, Yuka Nagao, Manabu Maeshiro, Asuka Iwamoto, Mayumi Hirayama, Ryoji Yoshida, Yoshihiro Komohara & Hideki Nakayama. (2022) Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration. Cancer Immunology, Immunotherapy 71:9, pages 2127-2139.
Crossref
Yue Gao, Yan Yue & Sidong Xiong. (2021) An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine. Frontiers in Immunology 12.
Crossref
Samantha Zottnick, Alessa L. Voß & Angelika B. Riemer. (2020) Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations. Frontiers in Immunology 11.
Crossref
Shiran Ferber, Rodrigo J. Gonzalez, Alexander M. Cryer, Ulrich H. Andrian & Natalie Artzi. (2019) Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines. Advanced Materials 32:13, pages 1903847.
Crossref
Mateusz Sikora, Magda Przesławska & Rafał Becht. (2019) HPV infections in head and neck cancers (HNSCC) – clinical course and efficiency of therapy. Pomeranian Journal of Life Sciences 65:3, pages 36-40.
Crossref
Kamila Hladíková, Simona Partlová, Vladimír Koucký, Jan Bouček, Jean-Francois Fonteneau, Michal Zábrodský, Ruth Tachezy, Marek Grega, Radek Špíšek & Anna Fialová. (2018) Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1. Oral Oncology 82, pages 75-82.
Crossref
A. Le Moignic, V. Malard, T. Benvegnu, L. Lemiègre, M. Berchel, P.-A. Jaffrès, C. Baillou, M. Delost, R. Macedo, J. Rochefort, G. Lescaille, C. Pichon, F.M. Lemoine, P. Midoux & V. Mateo. (2018) Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells. Journal of Controlled Release 278, pages 110-121.
Crossref
JKW Yap, D O'Neill, S Nagenthiran, CW Dawson & DM Luesley. (2017) Current insights into the aetiology, pathobiology, and management of local disease recurrence in squamous cell carcinoma of the vulva. BJOG: An International Journal of Obstetrics & Gynaecology 124:6, pages 946-954.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.